Using smartphone apps to help prevent relapse in people with opioid use disorder
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
This study is testing a smartphone app called OPTiMA to see if it can help people with opioid use disorder stay on track and avoid relapse, by giving them daily check-ins and personalized tips, while comparing it to a group that only gets regular monitoring.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-10844489 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of a smartphone application called OPTiMA, designed to help individuals with opioid use disorder prevent relapse. Participants will be randomly assigned to either use the app, which includes daily self-monitoring and personalized feedback, or to a control group that only receives monitoring. The study aims to understand how the app influences opioid use over six months and to explore the brain mechanisms involved in treatment response through neuroimaging. By leveraging mobile technology, the research seeks to provide innovative support for those undergoing medication-assisted treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults undergoing medication-assisted treatment for opioid use disorder.
Not a fit: Patients who are not currently receiving treatment for opioid use disorder or those who do not have access to smartphones may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a valuable tool for individuals in recovery from opioid use disorder, potentially reducing relapse rates and improving treatment outcomes.
How similar studies have performed: While smartphone apps have shown success in reducing other substance use, this specific approach for opioid use disorder is relatively novel and has not been extensively tested.
Where this research is happening
Little Rock, United States
- Univ of Arkansas for Med Scis — Little Rock, United States (Active)
Researchers
- Principal investigator: James, George Andrew — Univ of Arkansas for Med Scis
- Study coordinator: James, George Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.